Co-targeting TGF-ß and PD-L1 with radiation therapy: The Goldilocks principle.
Cell Rep Med
; 2(9): 100406, 2021 09 21.
Article
en En
| MEDLINE
| ID: mdl-34622240
In the current issue of Cancer Cell, Lan et al.1 demonstrate that a bifunctional fusion protein targeting TGF-ß and PD-L1 can synergize with radiation therapy to simultaneously augment tumor control and reduce normal tissue toxicity.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Antígeno B7-H1
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Cell Rep Med
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos